The preclinical oncology landscape has evolved over the past 10 years. We have seen overwhelming breakthroughs in both the development and application of advanced models of disease, ultimately leading to the bettering of patients' lives through pioneering pipelines and novel therapeutics.
As the only meeting dedicated to uniting this community of preclinical and translational leaders, the 10th Annual PREDiCT: Tumour Models Summit is excited to be returning online. We will be sharing fresh case studies on the application of tumour models from PDX to organoids to humanised mice.
Hear from GSK, Roche, UCB Celltech, Pathios Therapeutics as they delve into the most translatable models, preventing drug resistance, effectively translating efficacy, closing the preclinical gap, capturing the TME and more! Find out more in our full event brochure and check out our 3 exclusive workshops.
What's New For 2021?
Hear 28+ case studies from leading biopharma and academia
Join in the online discussion with workshops, networking and roundtables
Transform your model toolbox with exclusive insights into preclinical and translational data
Celebrate our 10th Anniversary with the tumour models community
Foster collaboration and innovation